"Global mRNA Therapeutics Market Overview:
Global mRNA Therapeutics Market is expected to grow at a significant rate during the forecast period 2025-2032, with 2024 as the base year.
Global mRNA Therapeutics Market Report 2025 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2025-2032.This research study of mRNA Therapeutics involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the mRNA Therapeutics Market:
The mRNA Therapeutics Market Research report incorporates value chain analysis for each of the product type. Value chain analysis offers in-depth information about value addition at each stage.The study includes drivers and restraints for mRNA Therapeutics Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study mRNA Therapeutics Market helps user to make precise decision in order to expand their market presence and increase market share.
By Type, mRNA Therapeutics market has been segmented into:
Rare Genetic Diseases
Oncology
By Application, mRNA Therapeutics market has been segmented into:
Prophylactic Vaccines
Therapeutic Vaccines
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The mRNA Therapeutics market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the mRNA Therapeutics market.
Top Key Players Covered in mRNA Therapeutics market are:
Moderna
Inc.
BioNTech SE
CureVac N.V.
Arcturus Therapeutics
Translate Bio
Inc.
GSK plc.
Argos Therapeutics Inc.
"
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Challenges
3.2 Market Trend Analysis
3.3 PESTLE Analysis
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Analysis
3.6 Ecosystem
3.7 Regulatory Landscape
3.8 Price Trend Analysis
3.9 Patent Analysis
3.10 Technology Evolution
3.11 Investment Pockets
3.12 Import-Export Analysis
Chapter 4: mRNA Therapeutics Market by Type
4.1 mRNA Therapeutics Market Snapshot and Growth Engine
4.2 mRNA Therapeutics Market Overview
4.3 Rare Genetic Diseases
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.3.3 Key Market Trends, Growth Factors and Opportunities
4.3.4 Rare Genetic Diseases: Geographic Segmentation Analysis
4.4 Oncology
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.4.3 Key Market Trends, Growth Factors and Opportunities
4.4.4 Oncology: Geographic Segmentation Analysis
Chapter 5: mRNA Therapeutics Market by Application
5.1 mRNA Therapeutics Market Snapshot and Growth Engine
5.2 mRNA Therapeutics Market Overview
5.3 Prophylactic Vaccines
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Prophylactic Vaccines: Geographic Segmentation Analysis
5.4 Therapeutic Vaccines
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Therapeutic Vaccines: Geographic Segmentation Analysis
Chapter 6: Company Profiles and Competitive Analysis
6.1 Competitive Landscape
6.1.1 Competitive Benchmarking
6.1.2 mRNA Therapeutics Market Share by Manufacturer (2023)
6.1.3 Industry BCG Matrix
6.1.4 Heat Map Analysis
6.1.5 Mergers and Acquisitions
6.2 MODERNA
6.2.1 Company Overview
6.2.2 Key Executives
6.2.3 Company Snapshot
6.2.4 Role of the Company in the Market
6.2.5 Sustainability and Social Responsibility
6.2.6 Operating Business Segments
6.2.7 Product Portfolio
6.2.8 Business Performance
6.2.9 Key Strategic Moves and Recent Developments
6.2.10 SWOT Analysis
6.3 INC.
6.4 BIONTECH SE
6.5 CUREVAC N.V.
6.6 ARCTURUS THERAPEUTICS
6.7 TRANSLATE BIO
6.8 INC.
6.9 GSK PLC.
6.10 ARGOS THERAPEUTICS INC.
Chapter 7: Global mRNA Therapeutics Market By Region
7.1 Overview
7.2. North America mRNA Therapeutics Market
7.2.1 Key Market Trends, Growth Factors and Opportunities
7.2.2 Top Key Companies
7.2.3 Historic and Forecasted Market Size by Segments
7.2.4 Historic and Forecasted Market Size By Type
7.2.4.1 Rare Genetic Diseases
7.2.4.2 Oncology
7.2.5 Historic and Forecasted Market Size By Application
7.2.5.1 Prophylactic Vaccines
7.2.5.2 Therapeutic Vaccines
7.2.6 Historic and Forecast Market Size by Country
7.2.6.1 US
7.2.6.2 Canada
7.2.6.3 Mexico
7.3. Eastern Europe mRNA Therapeutics Market
7.3.1 Key Market Trends, Growth Factors and Opportunities
7.3.2 Top Key Companies
7.3.3 Historic and Forecasted Market Size by Segments
7.3.4 Historic and Forecasted Market Size By Type
7.3.4.1 Rare Genetic Diseases
7.3.4.2 Oncology
7.3.5 Historic and Forecasted Market Size By Application
7.3.5.1 Prophylactic Vaccines
7.3.5.2 Therapeutic Vaccines
7.3.6 Historic and Forecast Market Size by Country
7.3.6.1 Bulgaria
7.3.6.2 The Czech Republic
7.3.6.3 Hungary
7.3.6.4 Poland
7.3.6.5 Romania
7.3.6.6 Rest of Eastern Europe
7.4. Western Europe mRNA Therapeutics Market
7.4.1 Key Market Trends, Growth Factors and Opportunities
7.4.2 Top Key Companies
7.4.3 Historic and Forecasted Market Size by Segments
7.4.4 Historic and Forecasted Market Size By Type
7.4.4.1 Rare Genetic Diseases
7.4.4.2 Oncology
7.4.5 Historic and Forecasted Market Size By Application
7.4.5.1 Prophylactic Vaccines
7.4.5.2 Therapeutic Vaccines
7.4.6 Historic and Forecast Market Size by Country
7.4.6.1 Germany
7.4.6.2 UK
7.4.6.3 France
7.4.6.4 Netherlands
7.4.6.5 Italy
7.4.6.6 Russia
7.4.6.7 Spain
7.4.6.8 Rest of Western Europe
7.5. Asia Pacific mRNA Therapeutics Market
7.5.1 Key Market Trends, Growth Factors and Opportunities
7.5.2 Top Key Companies
7.5.3 Historic and Forecasted Market Size by Segments
7.5.4 Historic and Forecasted Market Size By Type
7.5.4.1 Rare Genetic Diseases
7.5.4.2 Oncology
7.5.5 Historic and Forecasted Market Size By Application
7.5.5.1 Prophylactic Vaccines
7.5.5.2 Therapeutic Vaccines
7.5.6 Historic and Forecast Market Size by Country
7.5.6.1 China
7.5.6.2 India
7.5.6.3 Japan
7.5.6.4 South Korea
7.5.6.5 Malaysia
7.5.6.6 Thailand
7.5.6.7 Vietnam
7.5.6.8 The Philippines
7.5.6.9 Australia
7.5.6.10 New Zealand
7.5.6.11 Rest of APAC
7.6. Middle East & Africa mRNA Therapeutics Market
7.6.1 Key Market Trends, Growth Factors and Opportunities
7.6.2 Top Key Companies
7.6.3 Historic and Forecasted Market Size by Segments
7.6.4 Historic and Forecasted Market Size By Type
7.6.4.1 Rare Genetic Diseases
7.6.4.2 Oncology
7.6.5 Historic and Forecasted Market Size By Application
7.6.5.1 Prophylactic Vaccines
7.6.5.2 Therapeutic Vaccines
7.6.6 Historic and Forecast Market Size by Country
7.6.6.1 Turkey
7.6.6.2 Bahrain
7.6.6.3 Kuwait
7.6.6.4 Saudi Arabia
7.6.6.5 Qatar
7.6.6.6 UAE
7.6.6.7 Israel
7.6.6.8 South Africa
7.7. South America mRNA Therapeutics Market
7.7.1 Key Market Trends, Growth Factors and Opportunities
7.7.2 Top Key Companies
7.7.3 Historic and Forecasted Market Size by Segments
7.7.4 Historic and Forecasted Market Size By Type
7.7.4.1 Rare Genetic Diseases
7.7.4.2 Oncology
7.7.5 Historic and Forecasted Market Size By Application
7.7.5.1 Prophylactic Vaccines
7.7.5.2 Therapeutic Vaccines
7.7.6 Historic and Forecast Market Size by Country
7.7.6.1 Brazil
7.7.6.2 Argentina
7.7.6.3 Rest of SA
Chapter 8 Analyst Viewpoint and Conclusion
8.1 Recommendations and Concluding Analysis
8.2 Potential Market Strategies
Chapter 9 Research Methodology
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research
mRNA Therapeutics Scope:
|
Report Data
|
mRNA Therapeutics Market
|
|
mRNA Therapeutics Market Size in 2025
|
USD XX million
|
|
mRNA Therapeutics CAGR 2025 - 2032
|
XX%
|
|
mRNA Therapeutics Base Year
|
2024
|
|
mRNA Therapeutics Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Moderna, Inc., BioNTech SE, CureVac N.V., Arcturus Therapeutics, Translate Bio, Inc., GSK plc., Argos Therapeutics Inc..
|
|
Key Segments
|
By Type
Rare Genetic Diseases
Oncology
By Applications
Prophylactic Vaccines
Therapeutic Vaccines
|
